European Society for Medical Oncology (ESMO) Congress 2024 was held in Barcelona, Spain, bringing together the global oncology community to share the latest data, innovations, and advancements in cancer care.
CRA’s Brian Carpenter and Bhavesh Patel break down the key topics emphasized this year including antibody-drug conjugates (ADCs) and their expanding role across tumor types, immunotherapies continuing to gain ground in tumors with high unmet need, biomarkers and their utility in personalizing patient care, continued progress in the field of radionuclide therapy, and the potential of artificial intelligence (AI) applications in oncology.
Read the ESMO 2024 review here.
